Catalyst Biosciences, Inc

CBIO NASDAQ
CBIO
Catalyst Biosciences, Inc NASDAQ
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E

CBIO financial statements

An in-depth look to Catalyst Biosciences, Inc operating, investing, and financing activities

CBIO free cash flow for Q2 21 is -20.47M. For 2020, CBIO free cash flow was -55.31M and operating cash flow was -55.05M.

TTM
Cash from operating activities
Funds from operations
Changes in working capital
Cash from investing activities
Purchase/sale of business, net
Purchase/sale of investments, net
Capital expenditures
Other investing cash flow items, total
Cash from financing activities
Issuance/retirement of stock, net
Issuance/retirement of debt, net
Total cash dividends paid
Other financing cash flow items, total
Free cash flow